Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Clovis Oncology Inc (CLVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,497,176
  • Shares Outstanding, K 52,550
  • Annual Sales, $ 55,510 K
  • Annual Income, $ -346,400 K
  • 36-Month Beta 0.92
  • Price/Sales 44.98
  • Price/Cash Flow N/A
  • Price/Book 7.87

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.72 +16.56%
on 05/04/18
53.90 -9.78%
on 05/17/18
+3.53 (+7.83%)
since 04/25/18
3-Month
41.72 +16.56%
on 05/04/18
65.24 -25.46%
on 04/11/18
-8.21 (-14.44%)
since 02/23/18
52-Week
41.72 +16.56%
on 05/04/18
99.45 -51.10%
on 07/28/17
-6.41 (-11.65%)
since 05/25/17

Most Recent Stories

More News
CORRECTING and REPLACING Clovis Oncology to Present at the Bank of America Merrill Lynch Healthcare Conference 2018

Presentation and webcast time listed in first paragraph of release should read: Wednesday, May 16, 2018 at 11:20 AM local time (instead of Thursday, May 17, 2018 at 10:00 AM Pacific Time)....

CLVS : 48.63 (+2.34%)
Clovis Oncology to Present at the Bank of America Merrill Lynch Healthcare Conference 2018

Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the Bank of America Merrill Lynch Healthcare Conference...

CLVS : 48.63 (+2.34%)
Clovis (CLVS) Q1 Loss Wider Than Expected, Revenues Beat

Clovis (CLVS) witnesses wider year-over-year loss in the first quarter. However, the company's revenues beat estimates. Rubraca sales increase.

AZN : 37.04 (+0.43%)
CLVS : 48.63 (+2.34%)
TSRO : 51.76 (+6.55%)
BMY : 52.77 (+0.15%)
Consolidated Research: 2018 Summary Expectations for Catalent, MGIC Investment, United Rentals, Clovis Oncology, Pure Storage, and Chipotle Mexican Grill -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Catalent, Inc. (NYSE:CTLT),...

MTG : 10.49 (-1.13%)
PSTG : 20.74 (-1.19%)
CTLT : 38.86 (+0.13%)
CLVS : 48.63 (+2.34%)
CMG : 428.96 (-1.03%)
URI : 161.94 (-3.27%)
Clovis Oncology Announces First Quarter 2018 Operating Results

--All-comers and earlier-line ovarian cancer maintenance treatment indication approved in U.S. on April 6, 2018

CLVS : 48.63 (+2.34%)
What's in Store for Horizon Pharma (HZNP) in Q1 Earnings?

On Horizon Pharma's (HZNP) first-quarter 2018 earnings call, investors focus will be on the performance of its business units and key products.

ADVM : 6.15 (unch)
HZNP : 16.17 (+4.19%)
APVO : 5.43 (-0.55%)
CLVS : 48.63 (+2.34%)
Shares of CLVS Down 16.5% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Clovis Oncology (NASDAQ:CLVS) on April 17th, 2018 at $54.07. In approximately 2 weeks, Clovis Oncology has returned 16.51% as of today's recent price of $45.14.

CLVS : 48.63 (+2.34%)
Clovis Oncology Becomes Oversold (CLVS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

CLVS : 48.63 (+2.34%)
Clovis Oncology to Announce First Quarter 2018 Financial Results and Host Webcast Conference Call on May 8

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2018 financial results on Tuesday, May 8, 2018, after the close of the U.S. financial markets. Clovis' senior management...

CLVS : 48.63 (+2.34%)
Clovis Oncology Set to Possibly Rebound After Yesterday's Selloff of 3.75%

Clovis Oncology (NASDAQ:CLVS) traded in a range yesterday that spanned from a low of $47.95 to a high of $50.85. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $49.91...

CLVS : 48.63 (+2.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade CLVS with:

Business Summary

Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations....

See More

Key Turning Points

2nd Resistance Point 49.93
1st Resistance Point 49.28
Last Price 48.63
1st Support Level 47.67
2nd Support Level 46.71

See More

52-Week High 99.45
Fibonacci 61.8% 77.40
Fibonacci 50% 70.58
Fibonacci 38.2% 63.77
Last Price 48.63
52-Week Low 41.72

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar